ライフサイエンスコーパス: sexually active

1 rs with Ureaplasma spp were younger and more sexually active.

2 ounseling costs, and whether the patient was sexually active.

3 Many older adults are sexually active.

4 sal or other intimate relationship and to be sexually active.

5 asm, 4) dry orgasm, and 5) whether they were sexually active.

6 heir bodies (P =.004) were more likely to be sexually active.

7 clinics and 23% in the control clinics were sexually active.

8 men aged 15-19 years who had recently become sexually active.

9 e 3-year survivors who defined themselves as sexually active.

10 All patients were sexually active.

11 xually experienced, and 73.7% reported being sexually active.

12 of male and 50.0% of female recipients were sexually active.

13 nd across diverse communities of MSM who are sexually active.

14 ve-age women with cardiovascular disease are sexually active.

15 ften viewed as asexual or incapable of being sexually active.

16 (40.4%) of women and 437 (54.9%) of men were sexually active.

17 sted HIV negative in NHBS and were currently sexually active.

18 f vaccinating adolescents before they become sexually active.

19 ded women aged 18-39 years who had ever been sexually active.

20 eption for those youth who are or plan to be sexually active.

21 Chlamydia trachomatis screening rate for sexually active 14- to 18-year-old girls during routine

22 Compared to 2003-2006, 4vHPV prevalence in sexually active 14- to 24-year-olds in 2011-2014 decreas

23 Among sexually active 16-24-year-olds, 54.2% (51.4-56.9) of wo

24 HIV-seronegative, sexually active, 18-24-year-old Kenyan men participating

25 Of those who were sexually active, 47% reported no or little desire, 80% r

26 %; P<.001) and among those who had ever been sexually active (82.7%) than among those who had not (63

27 Among respondents who were sexually active, about half of both men and women report

28 hat men and women differed in rates of being sexually active across time (P < .001) and in overall se

29 We, therefore, recommend screening all sexually active adolescent females for chlamydia infecti

30 Although routine screening of all sexually active adolescent females for Chlamydia trachom

31 Sexually active adolescent girls (younger than 18 years)

32 terventional, randomised controlled trial of sexually active adolescent girls and young women (aged 1

33 reased the C trachomatis screening rates for sexually active adolescent girls during routine checkups

34 Although annual C trachomatis screening of sexually active adolescent girls is recommended by healt

35 For this purpose, sexually active adolescent women (n = 345) were recruite

36 he cumulative prevalence of HPV infection in sexually active adolescent women is extremely high, invo

37 continue with regular chlamydia screening in sexually active adolescent women, have a low index of su

38 ification (for C. trachomatis only) from 255 sexually active adolescent women.

39 and is a recommended contraceptive device in sexually active adolescent women.

40 Asymptomatic, sexually active adolescents and adults, including pregna

41 This recommendation applies to all sexually active adolescents and adults, including pregna

42 STF recommends behavioral counseling for all sexually active adolescents and for adults at increased

43 ends intensive behavioral counseling for all sexually active adolescents and for adults who are at in

44 s reduce the likelihood of acquiring STIs in sexually active adolescents and in adults at increased r

45 ary care and related settings, especially in sexually active adolescents and in adults at increased r

46 This recommendation statement applies to all sexually active adolescents and to adults at increased r

47 This recommendation applies to all sexually active adolescents and to adults who are at inc

48 ferent anatomic sites in a cohort of at-risk sexually active adolescents and young adults aged 12-24

49 ferent anatomic sites in a cohort of at-risk sexually active adolescents and young adults between 12-

50 Use of urine assays for screening sexually active adolescents has the potential to signifi

51 Among sexually active adolescents in psychiatric treatment (N=

52 Annual chlamydia screening of sexually active adolescents is an important method for e

53 In this cross-sectional study of sexually active adolescents presenting to the ED, the ma

54 For most sexually active adolescents, pregnancy is unintended.

55 through exposure as subadults to unrelated, sexually active adult males.

56 illomaviruses affect an estimated 75% of the sexually active adult population in the United States, w

57 mised trial that recruited HIV-1 uninfected, sexually active adults aged 18-35 years from five sites

58 ptomatic cutaneous neoplasms in children and sexually active adults as well as persistent opportunist

59 In the United States, 1 in 5 sexually active adults is infected.

60 Among sexually active adults, new genital HSV-1 infections are

61 is B vaccination provided to adolescents and sexually active adults.

62 A total of 72% of women were sexually active after transplantation.

63 via cohort vaccination of those entering the sexually active age classes, they could have a substanti

64 mbined, (i) the extremely high prevalence in sexually active AGMs, (ii) the very efficient SIV transm

65 in the cervicovaginal and introital sites in sexually active Amerindians (N = 82) spanning urbanizati

66 Of the 39 individuals enrolled, 28 had been sexually active and all had sexual difficulties.

67 nt adolescents and adults who have ever been sexually active and are at increased risk for syphilis i

68 This increased risk occurs in both sexually active and celibate men, suggesting that it ari

69 ects as more of the study population becomes sexually active and has increased demand for contracepti

70 Sexually active and HIV-negative MSM were recruited from

71 vid women, UI was associated with ever being sexually active and no COC use, as well as lower psychol

72 est rates reported by students who were ever sexually active and not using COCs (21.5% [CI, 16.7% to

73 health as being poor were less likely to be sexually active and, among respondents who were sexually

74 All sexually active and/or substance-using HIV-infected MSM

75 again at risk of infection when they become sexually active as adolescents.

76 Analyses included 209 women sexually active at baseline (78.6% of total sample).

77 Median time they had been sexually active at diagnosis was 3.2 years (2.6-6.5).

78 (46%) of 385 participants who reported being sexually active at enrolment reported abstinence at thei

79 Almost five percentage boys were sexually active at wave 1 whereas in wave 2, it rose to

80 Among people who were sexually active before and after AMI, women were less li

81 nce an acute myocardial infarction (AMI) are sexually active before the AMI, but little is known abou

82 The 59 participants sexually active before the trial were the main target of

83 s in the past 5 years with increased risk in sexually active black Caribbean (OR 2.74 [95% CI 1.22-6.

84 early sexual debut [Coef; 0.019; p < 0.01], sexually active [Coef: 0.058; p < 0.001] and reported wa

85 l, South Africa, who were HIV uninfected and sexually active consented to HIV-1 RNA testing twice a w

86 male sexual matters, assessed in a subset of sexually active, consenting females, did not differ sign

87 o HPV-naive women, and women who are already sexually active, could substantially reduce the incidenc

88 Only 1 seroconversion occurred among the 42 sexually active couples (23.7% of the 177 sexually activ

89 In contrast, the incidence in sexually active couples who infrequently used or did not

90 42 sexually active couples (23.7% of the 177 sexually active couples) who always used condoms.

91 cluded young, heterosexual, recently formed, sexually active couples.

92 s throughout the adult's life showed that on sexually active days, gene expression was significantly

93 Eligible women were aged 30-64 years, sexually active, did not have a history of cervical canc

94 ease in mast cells in the medial habenula of sexually active doves compared with controls.

95 Among the 177 couples who remained sexually active during the prospective study period, 20

96 iving care from a participating healer, were sexually active (ever had intercourse), self-reported no

97 These findings support screening sexually active female adolescents at each visit, even i

98 Screening guidelines recommend testing all sexually active female adolescents for Chlamydia trachom

99 se nonsexual risky behavior and pregnancy in sexually active female adolescents.

100 Among the 2288 sexually active female participants (56.7% white; 33.6%

101 Descriptive analyses were conducted among sexually active female students (n = 2288); logistic reg

102 istic regression analyses were restricted to sexually active female users of LARC and moderately effe

103 gs support current recommendations to screen sexually active females age 25 years or younger for chla

104 Among a cohort of 237 sexually active females aged 14-19 years recruited from

105 Sexually active females aged 14-21 years were randomized

106 loped a method to estimate the proportion of sexually active females aged 15-19 years screened for ch

107 sed, the median state-specific proportion of sexually active females aged 15-19 years screened in 200

108 USPSTF recommends screening for chlamydia in sexually active females aged 24 years or younger and in

109 USPSTF recommends screening for gonorrhea in sexually active females aged 24 years or younger and in

110 At enrollment, 260 (40%) of 650 sexually active females ages 14-19 years had an STD: chl

111 The presence of sexually active females also reduced sleep duration, by

112 s on-campus significantly increased 101% for sexually active females and significantly decreased 36%

113 rrhea remains insufficient at this time, all sexually active females younger than 25 years and all ol

114 95% CI, .03-.54) among participants who were sexually active for <=5 years before vaccination.

115 Significantly more of the sexually active gay men assessed via ACASI reported havi

116 Between 2017 and 2019, sexually active GBM in Montreal, Toronto, and Vancouver

117 targeting health promotion interventions at sexually active girls younger than 16 years and those wi

118 If sexually active, girls in this population often have sex

119 F-FTC prophylaxis prevented HIV infection in sexually active heterosexual adults.

120 Sexually active heterosexual male subjects aged 16-35 ye

121 anced efforts may be warranted to screen all sexually active HIV-infected adults for syphilis, chlamy

122 STD testing significantly increased among sexually active HIV-infected adults receiving medical ca

123 ilis, chlamydia, and gonorrhea testing among sexually active HIV-infected adults receiving medical ca

124 During 2009-2013, the proportion of sexually active HIV-infected adults receiving medical ca

125 Sexually active HIV-negative women ages 16-25 were offer

126 Nearly one-third of sexually active HIV-positive MSM were not tested annuall

127 % (95% confidence interval [CI]: 69%-73%) of sexually active HIV-positive MSM were tested for syphili

128 -blind trial in three South African sites in sexually-active, HIV-negative women, aged 16 years and o

129 We monitored 2393 sexually active HSV-2-seronegative persons for clinical

130 Current guidelines recommend that all sexually active human immunodeficiency virus (HIV)-infec

131 intain an erection, attain orgasm, and being sexually active in comparison with patients undergoing s

132 her; 41.6% and 41.8%, respectively, had been sexually active in the past 4 weeks.

133 her; 39.0% and 34.5%, respectively, had been sexually active in the past 4 weeks.

134 Proportions of women who had been sexually active in the past year changed over time in 43

135 are presented for the 858 patients who were sexually active in the year prior to the MI, with attent

136 ng any sexual partner in their lifetime) and sexually active individuals (those reporting any sexual

137 revalence of six psychiatric syndromes among sexually active individuals in the 1996 National Househo

138 We conducted a longitudinal study of 1139 sexually active, inner-city adolescent women receiving t

139 ith different needs over the course of their sexually active lifespan.

140 to use condoms were significantly higher for sexually active male students.

141 female rat will approach and withdraw from a sexually active male, thereby controlling the timing of

142 females and significantly decreased 36% for sexually active males.

143 There were 4,106 sexually active males; 1,227 reported they sired 2,323 p

144 As PHIV(+) youth become sexually active, many engage in behaviors that place the

145 = .15) or after excluding women who were not sexually active (mean [SD] difference, 2.9 [1.4] points

146 5.9% of 1221 sexually active men and 3.6% of 1560 sexually active wom

147 HPV infection is highly prevalent in sexually active men and can be detected by use of a vari

148 % CI 6%-10%; number of surveys [Ns] = 87) of sexually active men reported ever paying for sex.

149 Guidelines recommend that sexually active men who have sex with men (MSM) includin

150 threshold and begin to decline, with <1% of sexually active men who have sex with men infected regar

151 Anal swab samples were obtained from sexually active men who have sex with men.

152 Among the 59 sexually active men, follow-up data were obtained on 59

153 en over the age of 15 years and support that sexually active men, regardless of age, are an important

154 use, and viral load suppression (VLS) among sexually active men.

155 alence among unvaccinated 16- to 20-year-old sexually active men.

156 Participants aged 18-45 years who were sexually active, monogamous, not pregnant, and not sex w

157 perational costs of HIV-related services for sexually active MSM (defined as having sex with men in t

158 Sexually active MSM aged 18-45 years were administered a

159 valence of HPV infection is high among young sexually active MSM, with the anal canal being the most

160 Sexually-active MSM and transgender women without HIV wi

161 Men who were recently sexually active (n = 3323) were stratified on the basis

162 irth, aged 18-25 years, not living with HIV, sexually active, newly initiating PrEP, had regular acce

163 Participants were healthy, sexually active, non-pregnant, non-sterilised women aged

164 In this study, we used data from 6,654 sexually active nonpregnant women across 4 waves of the

165 We prospectively evaluated 796 sexually active, nonpregnant women from 18 through 40 ye

166 g female oral-contraceptive users than among sexually active nonusers.

167 examined, proportions of all women who were sexually active, not wanting to conceive, and not using

168 ren younger than 15 years who reported being sexually active or for whom testing was requested by a p

169 Sexually active participants reporting condomless sex wi

170 acilitated arm in a prespecified analysis of sexually active participants suggests that longer-term e

171 ies, those with siblings, and those who were sexually active, particularly if they had had numerous s

172 d diseases (STDs) in a greater proportion of sexually active patients has become an accepted protocol

173 In sexually active patients, the incremental cost-effective

174 s screening of all pregnant patients and all sexually active people aged 15 to 44 years and use of do

175 syphilis infections include (1) screening of sexually active people aged 15 to 44 years at least once

176 l sexually transmitted infection testing for sexually active people living with human immunodeficienc

177 GSCs produce numerous gametes throughout the sexually active period of adult life.

178 Most sexually active persons will have detectable HPV at leas

179 nst abnormal cytology was also diminished in sexually active PHIV females.

180 isk Behavior Survey on the proportion of the sexually active population aged 15-18 years.

181 for HIV prevention should target the general sexually active population and not only serodiscordant c

182 intended to simulate the size of the Black, sexually active population in New Orleans ages 15-24 yea

183 protects uninfected adolescents entering the sexually active population.

184 iciency virus (HIV)-infected individuals and sexually active populations at risk for HIV acquisition

185 xty-one percent of men and 37% of women were sexually active pre-HCT; the prevalence declined to 51%

186 Participants were sexually active, pregnancy-capable people aged 15 to 34

187 ough RSE is important so that as they become sexually active, rates of unprotected sex are reduced.

188 reases in use of reliable contraceptives for sexually active students.

189 plants, are used by only a small minority of sexually active teens, despite their endorsement by prof

190 behavioural survey data were collected among sexually active transgender women in the metropolitan mu

191 15-2019, in the previous 12 months, 63.3% of sexually active transgender women who were human immunod

192 6, 2018, and March 15, 2019, we enrolled 887 sexually active transgender women: 323 in Johannesburg,

193 Sexually active U.S. women 15 to 29 years of age.

194 Sexually active unvaccinated women and men aged 16 to 25

195 fections and pregnancy; however, only 52% of sexually active US adolescents used a condom at last int

196 gy occurred in 33 of 56 PHIV and 1 of 7 PHEU sexually active vaccinated females, yielding incidence r

197 ination campaign, women who were fertile and sexually active were counseled as part of the campaign b

198 form of contraception even if not currently sexually active were eligible.

199 ually active and, among respondents who were sexually active, were more likely to report sexual probl

200 associated but only among women not recently sexually active with male partners.

201 Half (48.7%) of adolescent were sexually active with mean age at sexual debut of 14.6+/-

202 elial lesions are common among women who are sexually active with women and occur among those who hav

203 dies, was investigated in 149 women who were sexually active with women.

204 s multicenter cross-sectional study enrolled sexually active women > or =18 years of age who presente

205 for gonorrhea and chlamydia in asymptomatic, sexually active women (including pregnant women) who are

206 Sexually active women (n = 74) were randomized to one of

207 Sexually active women (n=5,871) in the NCI-sponsored Cos

208 The Ring Study, a phase 3 trial in 1959 sexually active women (randomised 2:1), showed a favoura

209 matis infection is currently recommended for sexually active women 15 to 25 years old and for women o

210 for chlamydia and gonorrhea in asymptomatic, sexually active women 24 years or younger and in older w

211 TF recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 2

212 ertainty that screening for chlamydia in all sexually active women 24 years or younger and in women 2

213 ertainty that screening for gonorrhea in all sexually active women 24 years or younger and in women 2

214 TF recommends screening for chlamydia in all sexually active women 24 years or younger and in women 2

215 Analyses were based on sexually active women aged 15-49 years irrespective of m

216 4813 sexually active women aged 15-49 years were surveyed to

217 prevalence was defined as the percentage of sexually active women aged 15-49 years who (or whose par

218 %) and 20.9% (95% CI, 19.3%-22.4%) for other sexually active women and men, respectively.

219 trachomatis and N. gonorrhoeae infections in sexually active women and to prevent their costly and se

220 Reporting by sexually active women and women with a history of infert

221 esentativeness of our data, and our defining sexually active women as those who have ever had sex.

222 PSTF) recommended that clinicians screen all sexually active women at increased risk for infection fo

223 concurrently obtained plasma and sera in 710 sexually active women by using a glycoprotein G2-based e

224 it, clinicians collected cervical cells from sexually active women for cytology and HPV testing.

225 A total of 2353 sexually active women for whom cervicovaginal HPV infect

226 We used data on 12,684 sexually active women from a national survey conducted i

227 ive of sexually transmitted infection, among sexually active women in Brazil.

228 A total of 2017 sexually active women in the control arm of an HPV-16/18

229 randomised controlled trial in HIV-negative, sexually active women recruited from clinics and communi

230 of 1221 sexually active men and 3.6% of 1560 sexually active women reported use of STI-related servic

231 r of positive tests divided by the number of sexually active women screened by each sampling method d

232 ection has been strongly recommended for all sexually active women under the age of 26.

233 Vaginal lactobacilli isolated from 215 sexually active women were identified using whole-chromo

234 Many fertile and sexually active women who sought vaccination during UMUR

235 Sexually active women who were HIV negative were randoml

236 contraceptive users were compared with other sexually active women who were using either nonhormonal

237 Between 30% and 50% of sexually active women will encounter some type of FSD at

238 We assessed 2188 HIV-negative sexually active women with 2625 exposure intervals durin

239 vaginalis is found in virginal women and in sexually active women with a normal vaginal microbiota.

240 2 randomly selected women, 8554 nonpregnant, sexually active women without hysterectomies underwent i

241 prevention of HIV infection in 1959 healthy, sexually active women, 18 to 45 years of age, from seven

242 rvical lesions in a cross-sectional study of sexually active women, aged 18 to 50 years, from the Uni

243 We randomly assigned sexually active women, aged 18 years or older (>/=16 yea

244 sition and clearance were examined among 972 sexually active women, ages 18 to 85 years, recruited fr

245 llomavirus (HPV) infection is very common in sexually active women, but cervical cancer only develops

246 Among newly sexually active women, consistent condom use by their pa

247 e need for screening programs that cover all sexually active women, even if they were vaccinated.

248 Of the 47,585 fertile and sexually active women, the mean age was 28.0 years (stan

249 amined in a longitudinal cohort study of 751 sexually active women.

250 rachomatis infections are common among young sexually active women.

251 on interventions that target young, healthy, sexually active women.

252 ydia trachomatis infections are common among sexually active women.

253 cs of this intravaginal ring over 90 days in sexually active women.

254 roximating catch-up populations that include sexually active women; vaccine n=9319, control=9325).

255 oking practices in WSW, but longer-duration, sexually active WSW partnerships support a stable favora

256 measured in selected brain regions of young sexually active (YAM), young photoregressed (YPM), old r

257 Sexually active young adults in the small college town o

258 The incidence of HPV infection in sexually active young college women is high.

259 s study, we analyzed contraceptive use among sexually active young women aged 15-24 in the health zon

260 An estimated 80% of sexually active young women in the United States use hor

261 Among sexually active young women the incidence of symptomatic

262 We recruited sexually active young women who were starting a new meth

263 Cases were sexually active young women with acute UTI caused by Esc

264 virus (HPV) infection is highly prevalent in sexually active young women.

265 aseline finding from a diverse sample of 298 sexually active, young transgender women aged 16 through

266 Paired observations were available for 5,683 sexually active, young women (median age, 21 years).

267 Thirty-nine of 92 (42%) sexually active youth had HIV RNA >/=5000 copies/mL afte

268 Sixty-two percent (57/92) of sexually active youth reported unprotected SI.